171567-85-4 Usage
Description
D-Alanine, N-(methoxycarbonyl)(9CI) is a chemical compound derived from D-Alanine, a non-essential amino acid that plays a crucial role in protein synthesis and bacterial cell wall component formation. This derivative features a methoxycarbonyl group attached to the amino group of the alanine molecule, which can modify its properties and functions. It is widely utilized in the synthesis of peptides and other chemical compounds in laboratory settings, making it a valuable asset in organic and medicinal chemistry.
Uses
Used in Organic Chemistry:
D-Alanine, N-(methoxycarbonyl)(9CI) is used as a building block for the synthesis of various organic compounds due to its unique structure and reactivity.
Used in Medicinal Chemistry:
D-Alanine, N-(methoxycarbonyl)(9CI) is used as a key intermediate in the development of pharmaceuticals, particularly for the synthesis of peptide-based drugs, as its methoxycarbonyl group can influence the compound's properties and functions.
Used in Research and Development:
D-Alanine, N-(methoxycarbonyl)(9CI) is employed as a research tool in the study of amino acid derivatives and their potential applications in various fields, including drug discovery and material science.
Check Digit Verification of cas no
The CAS Registry Mumber 171567-85-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,1,5,6 and 7 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 171567-85:
(8*1)+(7*7)+(6*1)+(5*5)+(4*6)+(3*7)+(2*8)+(1*5)=154
154 % 10 = 4
So 171567-85-4 is a valid CAS Registry Number.
171567-85-4Relevant articles and documents
HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 84, (2012/02/15)
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Hepatitis C Virus Inhibitors
-
Page/Page column 50, (2010/10/19)
This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.
Synthesis and antidepressant activity of optical isomers of 2-(4-benzylpiperazin-1-yl)-1-(5-chloro-6-methoxynaphthalen-2-yl) propan-1-ol (SIPI5056)
Weng, Zhijie,Li, Jianqi
scheme or table, p. 1256 - 1259 (2010/06/15)
Four optical isomers of SIPI5056 were synthesized and evaluated for their antidepressant activities and acute toxicities as novel multiple reuptake inhibitors of monoamine transmitters. Chiral alanines were used as educts to prepare their respective target compounds in nine steps. Pharmacological results showed that the (1R,2S)-SIPI5056 isomer has higher inhibitory activity and lower toxicity than other three isomers and is worthy of further development.
